User profiles for Z. MARJANOVIC
Zdravko Marjanovic, PhDConcordia University of Edmonton, Department of Psychology Verified email at concordia.ab.ca Cited by 1656 |
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19
…, A Makatsariya, A Maneyro, Z Marjanovic… - The Lancet …, 2022 - thelancet.com
The International Initiative on Thrombosis and Cancer is an independent academic working
group of experts aimed at establishing global consensus for the treatment and prophylaxis of …
group of experts aimed at establishing global consensus for the treatment and prophylaxis of …
[HTML][HTML] Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for …
…, E Mousseaux, M Rovira, Z Marjanovic… - Bone Marrow …, 2017 - nature.com
Systemic sclerosis (SSc) is a rare disabling autoimmune disease with a similar mortality to
many cancers. Two randomized controlled trials of autologous hematopoietic stem cell …
many cancers. Two randomized controlled trials of autologous hematopoietic stem cell …
Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled …
G Meyer, Z Marjanovic, J Valcke… - Archives of internal …, 2002 - jamanetwork.com
Background The use of warfarin sodium for treating venous thromboembolism in patients
with cancer is associated with a significant risk of recurrence and bleeding. The use of low-…
with cancer is associated with a significant risk of recurrence and bleeding. The use of low-…
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial
… Vonk MC, Marjanovic Z, van den Hoogen FH, … Drs van Laar and Farge contributed equally
to this article as first authors and Drs Naraghi and Marjanovic contributed equally as third …
to this article as first authors and Drs Naraghi and Marjanovic contributed equally as third …
The relevance of psychosocial variables and working conditions in predicting nurses' coping strategies during the SARS crisis: an online questionnaire survey
Z Marjanovic, ER Greenglass, S Coffey - International journal of nursing …, 2007 - Elsevier
OBJECTIVES: The purpose of this investigation was to examine the relationship between
psychosocial variables and working conditions, and nurses’ coping methods and distress in …
psychosocial variables and working conditions, and nurses’ coping methods and distress in …
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
…, M Mandala, A Marayevas, Z Marjanovic… - The Lancet …, 2019 - thelancet.com
Venous thromboembolism (VTE) is the second leading cause of death in patients with cancer.
These patients are at a high risk of VTE recurrence and bleeding during anticoagulant …
These patients are at a high risk of VTE recurrence and bleeding during anticoagulant …
Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry
…, J Passweg, JM Van Laar, Z Marjanovic… - Annals of the …, 2004 - ard.bmj.com
Objective: To analyse the durability of the responses after haematopoietic stem cell
transplantation (HSCT) for severe systemic sclerosis (SSc) and determine whether the high …
transplantation (HSCT) for severe systemic sclerosis (SSc) and determine whether the high …
[HTML][HTML] Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies
…, S Sestilli, A Vekhof, E Brissot, Z Marjanovic… - Blood cancer …, 2021 - nature.com
This study evaluated the safety and immunogenicity of BNT162b2 vaccine in patients with
hematological malignancies. Antibodies blocking spike binding to immobilized ACE-2 (NAb) …
hematological malignancies. Antibodies blocking spike binding to immobilized ACE-2 (NAb) …
[HTML][HTML] COVID-19 outcomes in patients with hematologic disease
…, E Brissot, Z van de Wyngaert, Z Marjanovic… - Bone Marrow …, 2020 - nature.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus of
zoonotic origin that emerged in China at the end of 2019. The infection, named Coronavirus …
zoonotic origin that emerged in China at the end of 2019. The infection, named Coronavirus …
Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study b the Société Française de Greffe de Moelle et de Thérapie …
…, A Schmidt-Tanguy, Z Marjanovic… - Journal of clinical …, 2012 - orbi.uliege.be
Purpose : To investigate the impact of prior-to-transplantation azacitidine (AZA) on patient
outcome after allogeneic stem-cell transplantation (alloSCT) for myelodysplastic syndrome (…
outcome after allogeneic stem-cell transplantation (alloSCT) for myelodysplastic syndrome (…